Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3567611 A
Publication typeGrant
Publication date2 Mar 1971
Filing date16 Sep 1968
Priority date16 Sep 1968
Publication numberUS 3567611 A, US 3567611A, US-A-3567611, US3567611 A, US3567611A
InventorsMichel Richard E, Nalbandian Robert M
Original AssigneeGen Motors Corp
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Two-stage electromagnetophoresis
US 3567611 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

March 2, 1911 R. E MICHEL ETAL TWO-STAGE ELECTROMAGNETOPHORESIS Filed Sept. 16, 1968 l8- :4 no

United States Patent C) 3,567,611 TWO-STAGE ELECTROMAGNETOPHORESIS Richard E. Michel, Birmingham, and Robert M. Nalbandian, Bloomfield Hills, Mich.; said Michel assignor to General Motors Corporation, Detroit, Mich.

Filed Sept. 16, 1968, Ser. No. 759,884 Int. Cl. B01k 5/00 US. Cl. 204180 7 Claims ABSTRACT OF THE DISCLOSURE Material, such as human normal blood serum protein, is partitioned by two-stage electromagnetophoresis as a function of molecular paramagnetism. In the first stage the protein to be partitioned is positioned on a prism of gel and is electrophoresed to provide a first partition thereof in the direction of the applied electric field in accordance with physical and electrical characteristics thereof. Following the completion of the electrophoresis, the prism is placed in a non-uniform magnetic field and magnetophoresed. The proteins suspended in a partitioned state in the gel matrix as the result of electrophoresis are thus partitioned in a direction parallel to the magnetic field gradient as a function of the paramagnetism of the molecules of the protein.

BACKGROUND OF THE INVENTION Field of the invention The invention relates to partitioning techniques and refers more specifically to a method of partitioning human normal serum protein or the like by two-stage electromagnetophoresis as a function of molecular paramagnetism in which a material sample is electrophoresed and then magnetophoresed to provide displacement and grouping of molecules in accordance with their physical and electrical properties.

Description of the prior art In the past physical partitioning of material samples has been carried out in laboratories by known methods, such as chromatography, electrophoresis which has been done in many ways, ultra-centrifugation, counter-current separation, density gradient separation, dialysis, and the like. Simultaneous electromagnetophoresis has also been attempted in the past, however the separation arose from the force on a charged particle moving in a magnetic field. It is not believed that two-stage electromagnetophoretic partition of human normal serum protein or the like has been previously attempted.

SUMMARY OF THE INVENTION In accordance with the invention, two-stage electromagnetophoresis is accomplished by the method of first placing a sample of material to be partitioned on a gel prism and electrophoresing the sample, in a first stage, to provide a first partition thereof in accordance with the physical and electrical properties of the sample. The electrophoresed sample is then placed in a non-uniform magnetic field and magnetophoresed, in a second stage, to provide further partition of the sample in accordance with the paramagnetism of the molecules of the sample. The partition of the sample in the second stage is parallel to the magnetic field gradient.

The observed partition due to differential paramagnetic properties of the human normal serum proteins is another parameter by which isolation and characterization of the proteins is possible.

3,567,151 1 Patented Mar. 2, 1971 FIG. 1 is a top view of structure for accomplishing twostage electromagnetophoresis in accordance with the method of the invention.

FIG. 2 is a side view of the structure illustrated in FIG. 1.

FIG. 3 is a side view of structure for accomplishing electrophoresis in a standard procedure which has been done in many ways.

'FIG. 4 is a top view of structure for accomplishing the second stage of two-stage electromagnetophoresis in accordance with the method of the invention.

FIG. '5 is a side view of the structure illustrated in FIG. 4.

FIG. 6 is a pictorial illustration of the results of twostage electromagnetophoresis practiced by the method of the invention.

FIG. 7 is a pictorial illustration of a control sample useful in illustrating the difierence of two-stage electromagnetophoresis in comparison with electrophoresis alone.

DESCRIPTION OF THE PREFERRED EMBODIMENT In accordance with the method of the invention twostage electromagnetophoresis is accomplished by first filling a transparent plastic chamber 10, open at both ends, with a polyacrylamide gel 12. No spacer gel is used. Sodium persulfate is used to induce polymerization.

The method of providing the gel is fully set forth by Ornstein and Davis in their work, Disc Electrophoresis I, Background and Theory, Ann. N.Y. Acad. Sci. 121 :321-403, 1964, and Disc Electrophoresis II. Method and Application to Human Serum Proteins, Ann. N.Y. Acad. Sci. 121:404-436, 1964, respectively.

At one side on the top surface of the rectangular prism of gel 12 in a slight depression 0.1 to 0.2 ml. of human normal serum protein 14 is deposited. The system is then electrophoresed through use of the electrical apparatus 16 for thirty to forty-five minutes using a current of thirty milliamperes with a voltage range of volts to 320 volts delivered by a variable voltage power supply as a source of direct current.

Following the completion of the electrophoresis or first stage, the plastic chamber 10 with the gel 12 therein is placed for one hour in a non-uniform magnetic field generated by the electromagnet structure 18 where it is magnetophoresed. Typical values of the product of the magnetic field times the magnetic field gradient for the magnetophoresis, or second stage of the two-stage electromagnetophoresis, may be about twenty-five times 10 oersteds per centimeter squared.

As the result of the first stage or electrophoresis the human normal blood protein is separated vertically of the gel 12 in the chamber 10 into a plurality of separate layers of molecules having difierent physical and electrical properties, as shown diagrammatically in FIG. 3. The separation of the protein sample is evident when the gel is stained with a 0.1% amido-black solution and destained electrophoretically, as has been known in the past. A control sample of electrophoresed but not magnetophoresed protein is illustrated pictorially in FIG. 7.

Subsequent magnetophoresing of the electrophoresed protein sample produces movement of the partitioned protein sample suspended in the gel matrix parallel to the magnetic field gradient in which the gel is placed. The movement of the partitioned protein sample appears to be a function of paramagnetism of the individual molecules. Thus, the paramagnetic molecules undergo linear displacement in the non-uniform magnetic field (an established physical principle) whereby the serum sample is again partitioned, as shown pictorially in FIG. 6.

The partitioning of sample material by the method of two-stage electromagnetophoresis thereof is useful in diagnostic medical applications. For example, diagnosis of hemoglobinopathies and dysproteinemias may be possible using the two-stage electromagnetophoresis technique disclosed.

Two-stage electromagnetophoresis also may aid in physical partition problems occurring in biology and in the technology of the chemical and pharmaceutical industries. In addition, it is anticipated that in a more fundamental sense correlation will be found between new information about the structure of protein molecules resulting from two-stage electromagnetophoresis and avariety of diseases.

It is anticipated that the two-stage electromagnetophoresis disclosed herein may be used as a basic partition technique for other molecular systems (paramagnetic molecules with electrical charges) for which human normal serum proteins may be considered merely a general model. It is the intention to include all embodiments and modifications of the method of partition by electromagnetophoresis as are defined by the appended claims within the scope of the invention.

We claim:

1. The method of physical molecular partition, comprising separating a material sample by electrophoresis within a matrix in accordance with molecular physical and electrical properties thereof and additionally separating the sample by magnetophoresis within said matrix by placing it in a non-uniform magnetic field to produce movement of the molecules in a direction parallel to the magnetic field gradient in accordance with paramagnetism of the molecules thereof.

2. The method as set forth in claim 1 wherein the electrophoresis and magnetophoresis are carried out in two distinct and separate stages.

3. The method as set forth in claim 2 wherein the sample is electrophoresed before it is magnetophoresed.

4. The method as set forth in claim 1 wherein the material sample is human normal blood serum protein and the electrophoresis is accomplished in a polyacrylamide gel.

5. The method as set forth in claim 4 wherein the human normal blood serum protein is electrophoresed for thirty to forty-five minutes, using a current of approximately thirty milliamperes and a voltage variable between and 320 volts.

6. The method as set forth in claim 1 wherein the magnetic field is such that the product of the magnetic field strength times the magnetic field gradient is approximately times 10 oersteds per centimeter.

7. The method as set forth in claim 6 wherein the electrophoresed sample is placed in the non-uniform magnetic field for approximately one hour.

References Cited UNITED STATES PATENTS 3,140,714 7/1964 Murphy, Jr. et a1. 128214 3,207,684 9/1965 Dotts, Jr. 204 3,451,918 6/1969 Kolin 204299 3,479,277 11/1969 Kolin et a1 204299 OTHER REFERENCES Markham, A Modified Method of Two-Dimensional Zone Electrophoresis Applied to Mucoproteins in Serum and Urine, Nature, 17714499, pp. 125-126, Jan. 21, 1956.

JOHN H. MACK, Primary Examiner A. C. PRESCOTT, Assistant Examiner US. Cl. XvR- 204299

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3988230 *25 Mar 197626 Oct 1976Medac Gesellschaft Fur Klinische Spezial Praparate MbhChamber and process for crossed immunoelectro-phoresis
US3989612 *26 Dec 19742 Nov 1976The Upjohn CompanyBuffers, direct current
US4094759 *12 Jan 197713 Jun 1978Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.Electrophoretic migration toward a plurality of separate carrier strips
US4146454 *22 Jul 197627 Mar 1979Haber Instruments, Inc.Excitation, mobilizers, initiators
US4148703 *11 Feb 197610 Apr 1979Morton WeintraubMethod of electrophoretic purification of enzymes and peptides by means of an adjustable, specialized, geometrically located electrode system
US4385974 *24 Jun 198231 May 1983Jerry ShevitzElectrophoretic system and method for multidimensional analysis
US4693804 *19 Dec 198415 Sep 1987Board Of Regents, The University Of Texas SystemGel migration
US5167790 *18 May 19901 Dec 1992Washington UniversitySeparation of DNA or protein mixtures in size ranges not accessible to ordinary electrophoresis
US5185071 *30 Oct 19909 Feb 1993Board Of Regents, The University Of Texas SystemProgrammable electrophoresis with integrated and multiplexed control
US5338687 *11 Sep 199216 Aug 1994Lee Lawrence LDetection of biological macromolecules by NMR-sensitive labels
US5866303 *15 Oct 19972 Feb 1999Kabushiki Kaisha ToshibaResist developing method by magnetic field controlling, resist developing apparatus and method of fabricating semiconductor device
US627950230 Oct 199828 Aug 2001Kabushiki Kaisha ToshibaResist developing method by magnetic field controlling, resist developing apparatus and method of fabricating semiconductor device
Classifications
U.S. Classification204/462, 210/695, 204/545
International ClassificationG01N27/74, G01N27/447
Cooperative ClassificationG01N27/44786
European ClassificationG01N27/447C6